Clinical Trial Update: Safety Use of ATeGe in Liver Transplant Recipients With Pre-transplant Renal Dysfunction [Phase 3]

View source ↗

Summary

Phase 3 trial update on safety use of ATeGe in liver transplant recipients with pre-transplant renal dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplant Recipients with Renal Dysfunction

Drugs mentioned

• ATeGe

Snippet

Sponsor: Hospital Vall d'Hebron | Conditions: Renal Insufficiency | Phase 3 | Status: COMPLETED